Clinical Trials

A phase II, open label, non-controlled, intrapatient dose deescalation study to charachterize the pharmakokinatics after oral administration of eltrombopag in pediatric patients with refractory, relapsed, or treatment naïve severe aplastic anemia or reccurnet aplastic anemia


Research Study Number:
Pro2018-0135

Short Title:
ETB115

Division:
Bone Marrow Transplant

Study Status:
Enrolling